Farewell to a Stalwart: Dr. Lobsang Jampa Retires After Decades of Distinguished Service in Public Health

NAHARLAGUN,,Aug 5: A stalwart in the field of public health in Arunachal Pradesh, Dr. Lobsang Jampa, State Epidemiologist, was accorded a warm farewell today at the Directorate of Health Services (DHS), Naharlagun. The event was graced by Dr. Marbom Basar, Director of Health Services, Dr. Komling Perme, and other officers and officials of the Directorate, who gathered to honour his exemplary service and bid farewell to a true public health pioneer.

Over a remarkable public health career spanning 28 years and 3 months, Dr. Jampa made pioneering contributions that significantly shaped the health landscape of the state. Many in the fraternity rightly call him the “Father of Public Health” in Arunachal Pradesh, a testament to his trailblazing career and transformative impact. He is responsible for establishing the disease surveillance in the state.

Appointed as State Epidemiologist in 1999, his leadership was instrumental during several major health crises including the Avian Influenza outbreak in 2005, Swine Flu, and most notably the COVID-19 pandemic, where his strategic coordination and tireless efforts in outbreak response, containment, and public education earned widespread recognition.

Fondly remembered for his fieldwork during the early 2000s—when road connectivity was still a major challenge—Dr. Jampa personally led outbreak investigations across remote corners of the state, including Parsiparlo, Sunpura, and Menchuka. His hands-on approach, scientific acumen, and unwavering commitment earned him the State Gold Medal on 15th August 2015 in recognition of his outstanding service to the health sector.

Dr. Jampa was also an early and persistent advocate for systemic improvements in public health governance. He played a key role in pursuing the enhancement of the retirement age of government doctors to 62 years, alongside Dr. Alok Yirang and Dr. Pekba Ringu, during the tenure of Shri Satya Gopal, the then Development Commissioner.

Under his stewardship, numerous ICMR-supported studies were successfully implemented in the state, including research on Herpes Simplex, Hepatitis B screening in Anjaw, the India Diabetes Study (2012 & follow-up in 2022–2023), and a groundbreaking study on Paragonimiasis (lung fluke disease).

A visionary institution-builder, Dr. Jampa was pivotal in:

Facilitating land acquisition for patients in Vellore and for the National Centre for Disease Control (NCDC) at Hollongi.

Overseeing the construction of a protective boundary wall to safeguard the NCDC site.

Spearheading the establishment of the Health Emergency Operation Centre (HEOC) at TRIHMS in line with International Health Regulations (IHR) 2005.

Laying the groundwork for the state’s Public Health Cadre, a structural reform that promises to shape the future of health governance in Arunachal Pradesh.

His leadership also extended to the successful implementation of major national health programmes and schemes:

He was instrumental in establishing 12 District Dialysis Units under the Pradhan Mantri National Dialysis Programme (PMNDP), with three more units underway.

Dr. Jampa led the rollout of the Chief Minister Organ Transplant Scheme (CMOTS) in 2018, which has since facilitated over 200 successful kidney transplants.

He actively monitored and guided programmes such as NP-NCD, IDSP, HWC, NPCCHH, NRCP, and the National Viral Hepatitis Control Programme, among others.

In every capacity, Dr. Jampa brought vision, integrity, and an unmatched dedication to improving public health services across the state. His colleagues fondly recall his humility, relentless work ethic, and mentorship to younger professionals in the field.

As Dr. Lobsang Jampa retires on 31st July 2025, having attained the superannuation age of 62, he leaves behind a towering legacy that continues to inspire. The Department of Health Services extends its heartfelt gratitude and best wishes to Dr. Jampa for a peaceful and fulfilling retirement.

Leave a Reply

Your email address will not be published.